Erin Salter
Urology · Neenah, WINPI 1851754287
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (52.1%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 16 manufacturers reported payments, led by Intuitive Surgical at 52.1% of the total. Reporting peaked in 2023 at $5,016 and has fallen 92.2% since, to $390 in 2024.
Across 35 payments — averaging $164.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$3K
- Medtronic$1K
- Valencia Technologies Corporation$835
- Boston Scientific$365
- AbbVie$163
- Johnson & Johnson$25
- plus $176 from 10 others
What the payments were for
- Travel & lodging$1,82232%
- Food & beverage$94116%
- Education$3,00052%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 1 | $3,000 |
| Medtronic | 14 | $1,198 |
| Valencia Technologies Corporation | 2 | $835 |
| Boston Scientific | 2 | $365 |
| AbbVie(2 entities) | 5 | $163 |
| Johnson & Johnson | 1 | $25 |
| Bayer | 1 | $22 |
| Merck | 1 | $21 |
| Urogen Pharma, Inc. | 1 | $20 |
| C. R. Bard, Inc. & Subsidiaries | 1 | $18 |
| Sumitomo Pharma America, Inc. | 1 | $17 |
| Smith+Nephew | 1 | $17 |
| Teleflex LLC | 1 | $16 |
| Axonics, Inc. | 1 | $15 |
| Dendreon Pharmaceuticals LLC | 1 | $15 |
| Astellas Pharma US Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DAVINCI XI$3,000
- INTERSTIM$811
- eCoin Device Kit$764
How this compares
$5,763 in reported general payments places this provider in the 85th percentile of 215 urology providers in Wisconsin.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 85 | $42,100 |
| GemtesaVibegron | 41 | $35,529 |
| Estradiol | 54 | $4,612 |
| Tamsulosin Hcl | 174 | $2,293 |
| Methenamine Hippurate | 23 | $2,127 |
| Tolterodine Tartrate ErTolterodine Tartrate | 24 | $2,011 |
| Oxybutynin Chloride ErOxybutynin Chloride | 82 | $1,649 |
| Solifenacin Succinate | 22 | $699 |
| NitrofurantoinNitrofurantoin Macrocrystal | 16 | $528 |
| Desmopressin Acetate | 13 | $440 |
| Finasteride | 28 | $391 |
| Cephalexin | 31 | $227 |
| Oxybutynin Chloride | 22 | $144 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 42 | $110 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 19 | $108 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $14 | $42,10085 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $17 | $35,52941 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 215 urology providers in Wisconsin.
Other urology in Neenah
- Kevin FlynnNeenah$56K
- Eric LawatschNeenah$7K
- Dan GralnekMadison$142K
- Amy GuiseMilwaukee$106K
- Christopher ManakasMadison$87K
- Bahareh Alavi-DunnGreen Bay$62K
- Javier SantiagoMadison$57K
- Margaret KnoedlerMadison$31K
- Jeremy ReesePleasant Prairie$27K
- Edwin AbelMadison$22K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.